<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03356392</url>
  </required_header>
  <id_info>
    <org_study_id>GSR-ET</org_study_id>
    <nct_id>NCT03356392</nct_id>
  </id_info>
  <brief_title>German Stroke Registry - Endovascular Treatment</brief_title>
  <acronym>GSR-ET</acronym>
  <official_title>German Stroke Registry - Endovascular Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Göttingen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Bonn</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Frankfurt</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wuerzburg University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>RWTH Aachen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Technische Universität München</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Asklepios Klinik Altona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Klinikum Osnabrück</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Asklepios Klinik Wandsbek</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sana Klinikum Offenbach</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Klinikum Dortmund</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Krankenhaus Buchholz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Klinikum Lüneburg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>KRH Klinikum Nordstadt</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kliniken Köln</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bezirkskliniken Schwaben Bezirkskrankenhaus Günzburg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Klinikum Altenburger Land</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Klinikum Stadt Hanau</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universitätsklinikum Köln</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Klinikum Bremen-Mitte, gGmbH</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Uniklinikum Giessen und Marburg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Muenster</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Klinikum der Universitaet Muenchen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The German Stroke Registry (GSR) Endovascular Treatment is an academic, independent,
      prospective, multicentre, observational registry study. Consecutive patients treated with
      endovascular stroke treatment will be enrolled in German stroke centers. Patients receive
      regular care and data will be collected as part of clinical routine. Baseline clinical and
      procedural information as well clinical follow-up information during in-hospital stay, and up
      to 90 days of stroke onset are collected. Data collected include demographics, National
      Institute of Health Stroke Scale (NIHSS) on admission, pre-treatment ASPECTS, information on
      timing and success of interventional treatment, procedural complications, intracranial
      hemorrhage, and functional outcome.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 2015</start_date>
  <completion_date type="Anticipated">June 2025</completion_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>90 Days</target_duration>
  <primary_outcome>
    <measure>modified ranking scale on day (mRs) day 90</measure>
    <time_frame>90 days</time_frame>
    <description>mRs: modified ranking scale; the scale is a commonly used measurement for the degree of disability or dependence in the daily activities of people who have suffered a stroke; scale range 0-6, with 0 - No symptoms. 1 - No significant disability. Able to carry out all usual activities, despite some symptoms. 2 - Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. 3 - Moderate disability. Requires some help, but able to walk unassisted. 4 - Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. 5 - Severe disability. Requires constant nursing care and attention, bedridden, incontinent. 6 - Dead. publication: van Swieten J, Koudstaal P, Visser M, Schouten H, et al. (1988). &quot;Interobserver agreement for the assessment of handicap in stroke patients&quot;. Stroke. 19 (5): 604-607. doi:10.1161/01.str.19.5.604. PMID 3363593.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">2500</enrollment>
  <condition>Acute Ischemic Stroke</condition>
  <arm_group>
    <arm_group_label>stroke patients</arm_group_label>
    <description>acute stroke patients treated with endovascular treatment combined with thrombolysis or without previous thrombolysis Intervention: telephone call on day 90 to assess the primary outcome (mRs d90)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>telephone call d90</intervention_name>
    <description>telephone call on day 90 to assess the primary outcome (mRs d90)</description>
    <arm_group_label>stroke patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        all acute stroke patients with the clinical diagnosis of acute ischemic stroke, eligible
        for IVT and IVT initiated within 4.5 hours after stroke onset, Age &gt;18 years
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of acute ischemic stroke

          -  Eligible for intravenous thrombolysis (IVT) and IVT initiated within 4.5 hours after
             stroke onset

          -  Confirmed diagnosis of persistent occlusion of terminal carotid artery, middle
             cerebral artery (M1 or M2), or basilar artery consistent with symptoms

          -  Age &gt;18 years

          -  Ethic approval in process

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Dichgans, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>LMU, Munich, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christian Gerloff, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>UKE, Hamburg, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anna Christina Alegiani, Dr</last_name>
    <phone>0049-15222816679</phone>
    <email>a.alegiani@uke.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Frank Wollenweber, PD Dr.</last_name>
    <phone>+49 (0)89 4400 - 46046</phone>
    <email>frank.wollenweber@med.uni-muenchen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Medical Center Hamburg-Eppendorf (UKE)</name>
      <address>
        <city>Hamburg</city>
        <zip>20251</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Alegiani</last_name>
      <email>a.alegiani@uke.de</email>
    </contact>
    <contact_backup>
      <last_name>Götz Thomalla</last_name>
      <email>thomalla@uke.de</email>
    </contact_backup>
    <investigator>
      <last_name>Christian Gerloff</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 22, 2017</study_first_submitted>
  <study_first_submitted_qc>November 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 29, 2017</study_first_posted>
  <last_update_submitted>January 26, 2018</last_update_submitted>
  <last_update_submitted_qc>January 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>acute stroke, thrombectomy, endovascular treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

